Neuren Pharmaceuticals Limited Financial Overview
Neuren Pharmaceuticals Limited's market cap is currently $2.41B. The company's EPS TTM is AU$0.119; its P/E ratio is 16.28; Neuren Pharmaceuticals Limited is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is AU$-0.03. See an overview of income statement, balance sheet, and cash flow financials.
